July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Clinical and Anatomic Outcomes of Phacovitrectomy Surgery in Proliferative Diabetic Retinopathy
Author Affiliations & Notes
  • Talisa E de Carlo
    Ophthalmology, University of Illinois at Chicago, Chicago, Illinois, United States
  • Shilpa Gulati
    Ophthalmology, University of Illinois at Chicago, Chicago, Illinois, United States
  • Ivy Zhu
    Ophthalmology, University of Illinois at Chicago, Chicago, Illinois, United States
  • Elmer Tu
    Ophthalmology, University of Illinois at Chicago, Chicago, Illinois, United States
  • William F Mieler
    Ophthalmology, University of Illinois at Chicago, Chicago, Illinois, United States
  • Footnotes
    Commercial Relationships   Talisa de Carlo, None; Shilpa Gulati, None; Ivy Zhu, None; Elmer Tu, None; William Mieler, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 856. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Talisa E de Carlo, Shilpa Gulati, Ivy Zhu, Elmer Tu, William F Mieler; Clinical and Anatomic Outcomes of Phacovitrectomy Surgery in Proliferative Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2018;59(9):856.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Studies have noted the benefits of phacovitrectomy over pars plana vitrectomy (PPV) with subsequent cataract surgery for proliferative diabetic retinopathy (PDR) may include improved intraoperative view through a clear lens, avoidance of additional anesthesia, lower financial cost to patients, and a quicker visual recovery time frame. However, past studies have also raised concerns that there may be increased risk of iris neovascularization (NVI) and neovascular glaucoma with a variable rate of 0-15%. This is a retrospective study of the clinical and anatomic outcomes of concurrent phacovitrectomy surgery in eyes with PDR.

Methods : Retrospective study of all patients who underwent phacovitrectomy with the same cornea and vitreoretinal surgeons (2010-17). Eyes with prior surgery, trauma, or retinal co-morbidities were excluded. Pre-operative data collected included age, gender, visual acuity, surgical indication(s), intra-operative complications. Post-operative data was collected at post-operative months 1, 3, 6, 9, 12, and last visit (>12 months). Each visit data included visual acuity, anatomic status, and complications.

Results : 26 PDR eyes of 23 patients were included for the indication of tractional retinal detachment (TRD) (14 eyes, group 1) or non-clearing vitreous hemorrhage (VH) without TRD (12 eyes, group 2). Mean follow-up was 28.7 months. In group 1, vision between pre-operative and 1 year post-operative visits was statistically unchanged from -1.03 to -1.46 (p=0.31), but in group 2, vision improved from -1.175 to -0.195 (p=0.005). In group 1 33% improved by at least one line of visual acuity and 77% showed anatomic improvement compared with 100% visual and anatomic improvement in group 2. The most common complications in group 1 were VH (5 eyes, 36%) and recurrent RD (4 eyes, 29%). NVI occurred in 2 eyes (14%) during the follow-up period. Three eyes required repeat PPV for indications other than silicone oil removal. In group 2, CME was noted in 2 eyes (17%) and VH was seen in 1 eye (8%), which required repeat PPV. No NVI was seen.

Conclusions : Concurrent phacovitrectomy is an effective surgical approach for patients with PDR. Visual outcomes were improved in eyes without pre-operative TRD but unchanged in eyes with TRD. Surgical goals were achieved in all cases, and post-operative complication rates were comparable to historical rates of PPV alone. NVI was noted in only 7.7% of eyes.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×